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An RMND1 Mutation Causes Encephalopathy Associated
with Multiple Oxidative Phosphorylation Complex
Deficiencies and a Mitochondrial Translation Defect
Alexandre Janer,1,2,4 Hana Antonicka,2,4 Emilie Lalonde,1 Tamiko Nishimura,2 Florin Sasarman,2
Garry K. Brown,3 Ruth M. Brown,3 Jacek Majewski,1 and Eric A. Shoubridge1,2,*
Mutations in the genes composing the mitochondrial translation apparatus are an important cause of a heterogeneous group of oxida-
tive phosphorylation (OXPHOS) disorders. We studied the index case in a consanguineous family in which two children presented with
severe encephalopathy, lactic acidosis, and intractable seizures leading to an early fatal outcome. Blue native polyacrylamide gel electro-
phoretic (BN-PAGE) analysis showed assembly defects in all of the OXPHOS complexes with mtDNA-encoded structural subunits, and
these defects were associated with a severe deficiency in mitochondrial translation. Immunoblot analysis showed reductions in the
steady-state levels of several structural subunits of the mitochondrial ribosome. Whole-exome sequencing identified a homozygous
missensemutation (c.1250G>A) in an uncharacterized gene, RMND1 (required for meiotic nuclear division 1). RMND1 localizes tomito-
chondria and behaves as an integral membrane protein. Retroviral expression of the wild-type RMND1 cDNA rescued the biochemical
phenotype in subject cells, and siRNA-mediated knockdown of the protein recapitulated the defect. BN-PAGE, gel filtration, and mass
spectrometry analyses showed that RMND1 forms a high-molecular-weight and most likely homopolymeric complex (~240 kDa) that
does not assemble in subject fibroblasts but that is rescued by expression of RMND1 cDNA. The p.Arg417Gln substitution, predicted to
be in a coiled-coil domain, which is juxtaposed to a transmembrane domain at the extreme C terminus of the protein, does not alter
the steady-state level of RMND1 but might prevent protein-protein interactions in this complex. Our results demonstrate that the
RMND1 complex is necessary for mitochondrial translation, possibly by coordinating the assembly or maintenance of the mitochon-
drial ribosome.Mitochondria contain their own translationmachinery for
the synthesis of the 13 mtDNA-encoded polypeptides that
are essential structural components of the oxidative phos-
phorylation (OXPHOS) complexes. Whereas the mito-
chondrial genome (mtDNA) itself codes for the two rRNAs
and 22 tRNAs necessary for translation, all of the other
components of the translation apparatus are encoded in
the nucleus and must be targeted to the mitochondrion.
Mutations in genes affecting mitochondrial translation
are common causes of OXPHOS disorders in adults and
children.1,2 For instance, mutations in all of the mito-
chondrial tRNAs have been associated with disease, and
although they make up less than 10% of mtDNA, they
account for a large proportion of mtDNAmutations associ-
ated with human mitochondrial disease.3 Most of the
diseases that have been identified in the nuclear-encoded
components of the translation machinery are early-onset,
fatal disorders that are inherited in an autosomal-recessive
fashion.2 Although not universally true, many of the
translation defects cause deficiencies in more than one
OXPHOS complex. There is, however, a great deal of het-
erogeneity (often gene specific, but not always) in pheno-
typic presentation, which is an enduring mystery. In
addition, it is likely that many translation factors remain
unknown as new factors continue to be identified by the
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The AmericIn this study, we investigated a subject who presented
with an encephalopathy and lactic acidosis. Informed
consent was obtained, and the institutional review board
at the Montreal Neurological Institute approved the
research studies. The subject, a girl, was the fourth child
of consanguineous parents. There are three older female
siblings, the first two of whom are normal. The third
daughter developed intractable seizures at 2 months of
age, and a computed tomography (CT) scan showed cere-
bral atrophy and microcephaly. She died at the age of
13 months. The proband was normal at birth but devel-
oped seizures on day 6. She was hypotonic and required
tube feeding. At 4 months of age, she had unremitting
seizures and her head circumference was not increasing.
The liver was slightly enlarged, but there was no spleno-
megaly. The blood lactate concentration was 3.56 mmol/l
(the normal range is 0.63–2.44 mmol/l), and the cerebro-
spinal-fluid lactate concentration was 3.43 mmol/l (the
normal range is 0.90–2.80 mmol/l). The lactate to pyruvate
ratio in the blood was 21.2 (the normal ratio is 10–20).
Blood ammonia, urine amino acids, and organic acids
and lysosomal-enzyme studies were all normal. Cyto-
chrome c oxidase (COX) activity in cultured fibroblasts
was 4 nmol/mg protein/min (the normal range is 30–90),
and the COX to citrate synthase ratio was 0.11 (normal
is >1). The subject died at 5 months of age. At autopsy,Montre´al, QC H3A 1B1, Canada; 2Montreal Neurological Institute, McGill
ent of Biochemistry, University of Oxford, South Parks Road, Oxford OX1
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Figure 1. Characterization of Biochemical and Molecular
Defects in Subject Fibroblasts
Control and subject fibroblasts were analyzed by BN-PAGE (A) and
by pulse labeling of the mtDNA-encoded polypeptides (B).
(A) Each of the five OXPHOS complexes (I–V) was visualized with
a subunit-specific antibody that recognizes the native complex
as follows: CoI (NDUFA9), CoII (SDHA), CoIII (UQCRC1), CoIV
(COX4), CoV (ATP5A1). Complex II is the loading control.
(B) The seven subunits of complex I (ND), one subunit of complex
III (cyt b), three subunits of complex IV (COX), and two subunits
of complex V (ATP) are indicated to the right of the figure.
Figure 2. Steady-State Levels of Mitochondrial DNA, mRNAs,
rRNAs, and Mitochondrial-Translation Proteins
(A) Southern blot analysis of genomic DNA extracted from control
and subject fibroblasts. Hybridization was performed with probes
directed against a 16 kb fragment of the mitochondrial genome,
and the nuclear 18S rRNA gene was used as a loading control.
(B) Northern blot analysis carried out with total RNA extracted
from control and subject fibroblasts. Hybridization was performed
with probes specific to mitochondrial mRNAs encoding the three
COX subunits, one of the complex I subunits (ND1), and the 12S
and 16Smitochondrial ribosomal RNAs. Beta-actin was used as the
loading control.
(C) Immunoblot analysis of control and subject fibroblasts with
antibodies against the mitochondrial-translation elongation
factors (EFG1and EFTs) and the mitochondrial ribosomal proteins
MRPL32 (a kind gift of T. Langer, Cologne), MRPL13,MRPL15, and
MRPS2 (kind gifts of L. Spremulli, UNC Chapel Hill). The 70 kDa
subunit of complex II (SDHA) was used as a loading control.the brain showed marked atrophy of the cortex but a rela-
tively normal cerebellum and brain stem. The cord was
also atrophic. There was symmetrical ventricular dilata-
tion, and the corpus callosum was thin. Microscopically,
there was widespread vacuolation of cortical gray matter
and status spongiosus and extensive loss of myelin in the
brain stem.
To further investigate the nature of the biochemical
defect, we first immortalized the subject fibroblasts as
described previously.5 The COX activity in these cells was
26 5 11% of control levels (n ¼ 34). BN-PAGE analysis6
revealed marked assembly defects in complexes I, III, IV,
and V (Figure 1A), suggesting a mitochondrial-translation
defect. Confirming this prediction, the synthesis of the
mtDNA-encoded polypeptides, investigated by pulse label-
ing the mitochondrial translation products with a mixture
of [35S] methionine and [35S] cysteine,7 was severely and
uniformly decreased to <20% of control levels (Figure 1B).
Although this pattern of mitochondrial-translation defi-
ciency is similar to that found in other subjects with
genetically defined mitochondrial-translation defects,8–10
it represents the most severe generalized mitochondrial-
translation decrease that we have observed.
Southern blot analysis of subject fibroblasts showed
no decrease in the level of mtDNA when normalized to
the cytoplasmic 18S rRNA gene (Figure 2A), excluding
a mtDNA depletion syndrome. Northern blot analysis738 The American Journal of Human Genetics 91, 737–743, Octoberof several mitochondrial mRNAs (normalized to actin
mRNA) showed an increase of 2–5 fold in all of those exam-
ined (Figure 2B). The 12S mitochondrial rRNA level was
also 1.53 higher in subject fibroblasts than in controls;
however, the 16S rRNA was relatively decreased (0.83 the
control) (Figure 2B). Immunoblot analysis, carried out on
fibroblasts solubilized in 1.5% lauryl maltoside, showed
near control levels of the mitochondrial-translation elon-
gation factors but severely decreased levels of several mito-
chondrial ribosomal subunits (MRPL13, MRPL32, and
MRPS2) (Figure 2C), suggesting that the mitochondrial-
translation defect could be due to impaired assembly or
maintenance of the mitochondrial ribosome.
Microcell-mediated chromosome-transfer studies11 and
sequencing of several candidate genes failed to reveal a
causative mutation, so we used whole-exome sequencing
to search for a homozygous mutation. DNA from exonic
regions was captured with the Agilent SureSelect Human
All Exon Kit v.1 and sequenced on one lane of an
Illumina GAIIx with single-end sequencing of 76 bp
reads. Read alignment and variant identification were
performed as previously described.12 The average coverage
in the National Center for Biotechnology Information
Consensus Coding Sequence was 23.53, resulting in
approximately 65,000 variants passing the SAMtools
varFilter13 (default parameters, as well as a minimum SNP5, 2012
Figure 3. Mutational Analysis of RMND1 and Mitochondrial Localization of the Protein
(A) DNA sequence analysis of RMND1 cDNA indicates the position of the homozygous c.1250G>Amutation in the subject compared to
the control.
(B) A schematic representation of RMND1 (not to scale) shows the predicted domains and the position of the p.Arg417Gln substitution.
The following abbreviations are used: MLS, mitochondrial localization signal; DUF155, domain of unknown function 155; CC, coiled-
coil domain; and TM, transmembrane domain.
(C) The alignment of the amino acid sequences of RMND1 homologs in different species shows that the mutated arginine (black rect-
angle) is conserved only in the vertebrates.
(D) Control fibroblasts transiently expressing RMND1-EGFP (left panel, green) were incubated with an antibody against the mitochon-
drial protein SLIRP (middle panel, red). The far right panel showing the overlay is counterstained with DAPI for visualization of the
nucleus.
(E) Alkaline carbonate extraction of mitochondria fromHEK cells stably expressing a C-terminalMyc-tagged RMND1. Immunoblot anal-
ysis with anMyc antibody shows that RMND1 is an integral membrane protein. SDHA (soluble, membrane-associated protein) and COX
subunit 2 (integral inner membrane protein) were used as controls.quality of 20 and a minimum indel quality of 50, were
used). This number was significantly reduced to approxi-
mately 1,000 candidates after we filtered any previously
identified variants in dbSNP (v.131), the 1000 Genomes
Project (July 2010 release), and ten local exomes. In addi-
tion, because of the subject’s consanguinity, homozygous
nonsynonymous alleles were prioritized, leading to only
22 candidates. Finally, we searched for known and pre-
dicted mitochondrial proteins (by using the Mitocarta
database14), and RMND1 (required for meiotic nuclear
division 1), an uncharacterized gene, emerged as the only
candidate. Sanger sequencing of RMND1 in the subjectThe AmericcDNA and genomic DNA confirmed the homozygous mis-
sense mutation (c.1250G>A) identified by whole-exome
sequencing (Figure 3A); this mutation was predicted to
cause amino acid substitution p.Arg417Gln (RefSeq acces-
sion number NM_017909.2). DNA was not available for
analysis from any of the other family members.
Bioinformatic analysis of the protein sequence revealed
the presence of a DUF155 domain (Figure 3B) that is shared
by members of the RMD1/Sif2 family comprising RMD1
(the yeast homolog of RMND1) and four other yeast genes,
viz., RMD8, SIF2, SIF3, and YDR282C. RMND1 is also pre-
dicted to contain a mitochondrial localization signal atan Journal of Human Genetics 91, 737–743, October 5, 2012 739
Figure 4. Rescue of the Biochemical Phenotype by RMND1 Expression and Recapitulation of the Defect by siRNA-Mediated Knock-
down of the Protein
(A) BN-PAGE analysis of controls and subject fibroblasts expressing RMND1 from a retroviral vector (pBABE). Each of the five OXPHOS
complexes (I–V) was visualized with a subunit-specific antibody.
(B) Immunoblot analysis of the same samples as in (A) for expression of RMND1, individual structural subunits of the five OXPHOS
complexes, and two mitochondrial ribosomal subunits. The 70 kDa subunit of complex II (SDHA) was used as a loading control.
(C) Analysis of mitochondrial translation products in control and subject fibroblasts transduced with retroviral vectors expressing
RMND1-HA or RMND1-flag.
(D) Stealth RNAi-mediated knockdown of RMND1. The upper panel shows the level of knockdown of RMND1 on an immunoblot
with VDAC1 (porin) as a loading control. The bottom panel shows the BN-PAGE analysis in the control, RMND1 knockdown, and
subject cells.the N terminus and a coiled-coil domain (where the muta-
tion is localized) juxtaposed to a transmembrane domain
at the extreme C terminus (Figure 3B).
RMND1 is evolutionarily conserved down to yeast (from
which the name is derived), but the S. cerevisiae gene
product is reported to be cytosolic in a high-throughput
study of the cellular localization of the gene products ex-
pressed from genes chromosomally tagged with green fluo-
rescent protein.15 All the other members of the SIF2 family
are thought to have either nuclear or cytosolic localiza-
tions. Alignment of the amino acid sequences of RMND1
homologs (Figure 3C) shows that the mutated residue is
only conserved in vertebrates (40 of 40 vertebrates for
which the complete RMND1 sequence is available in
Ensembl). For confirming the mitochondrial localiza-
tion of RMND1, control fibroblasts transiently expressing
RMND1-EGFP were grown on coverslips, fixed with 4%
paraformaldehyde, and analyzed by immunofluorescence.
This analysis showed a nearly perfect colocalization of the
EGFP signal with mitochondria detected with a SLIRP anti-
body (Figure 3D). Alkaline carbonate extraction of isolated
mitochondria5 from a stable human embryonic kidney
(HEK) cell line expressing RMND1-Myc demonstrated that
it behaves as an integral membrane protein (Figure 3E).
Similar results were obtained for the native protein in
both control and subject fibroblasts (data not shown).
To confirm the pathogenicity of the RMND1 muta-
tion, we used a retroviral vector to express the wild-type740 The American Journal of Human Genetics 91, 737–743, OctoberRMND1 cDNA in subject fibroblasts. The RMND1 cDNA
was amplified by OneStep RT-PCR (QIAGEN) with specific
primers modified for Gateway-compatible vectors and was
cloned into pBABE, modified to be Gateway-compatible.4
The Phoenix packaging cell line was transiently trans-
fected with the retroviral construct according to the
HBS/Ca3(PO4)2 method (see Web Resources). Fibroblasts
were infected 48 hr later by exposure to virus-containing
medium in the presence of 4 mg/ml of polybrene.4 Expres-
sion of the wild-type RMND1 cDNA rescued the assembly
defects in the OXPHOS complexes (Figure 4A). (RMND1
C-terminally tagged with either a flag or Myc epitope also
rescued the assembly defects; data not shown). Immuno-
blot analysis with a polyclonal antibody (Sigma) raised
against a peptide antigen (amino acids 336–412) of
RMND1 showed a specific 35 kDa band that increased in
intensity when the cDNAwas expressed from the retroviral
vector (Figure 4B), suggesting that RMND1 is processed
beyond the mitochondrial localization sequence (amino
acid residue 32, predicted by MITOPROT) because the
molecular weight of that species would be 48 kDa. Consis-
tent with this interpretation, analysis of immunopre-
cipitated RMND1 by mass spectrometry (n ¼ 7) failed to
identify a peptide N terminal of amino acid 127, whereas
the coverage of the protein C terminal to this residue was
73%. The steady-state level of RMND1 in subject fibro-
blasts was similar to that in controls (Figure 4B), indicating
that the mutation does not destabilize the protein and that5, 2012
Figure 5. RMND1 Is Part of a High-Molecular-Weight Protein
Complex that Does Not Assemble in the Subject
(A) Size-exclusion-chromatography analysis was carried out with
mitochondria from HEK cells expressing RMND1-Myc. Immuno-
blotting with antibodies against either the native protein or the
Myc epitope demonstrated that both the endogenous and overex-
pressed proteins are part of a complex of about 240 kDa. The COX
subunit 1 of COX (230 kDa) and LRPPRC (250 kDa) were used as
molecular-weight references.
(B) BN-PAGE analysis of control and subject fibroblasts expressing
RMND1-Myc from a retroviral vector. An antibody directed against
the native protein shows that RMND1 forms a 250 kDa complex
that does not assemble in the subject. The complex is restored in
subject cells expressing RMND1-Myc. SDHA was used as a loading
control.the phenotype is most likely due to a loss of function of
the mutant RMND1. The steady-state levels of all analyzed
OXPHOS-complex components, as well as mitochondrial
ribosomal proteins in subject fibroblasts expressing the
wild-type RMND1 cDNA, were also comparable to levels
in controls (Figure 4B). Finally, we tested whether expres-
sion of the wild-type RMND1 rescued the mitochondrial-
translation defect in subject fibroblasts. Mitochondrial
protein synthesis was completely restored by retroviral
expression of either RMND1-Myc or RMND1-flag in subject
fibroblasts (Figure 4C).
To further investigate the function of RMND1, we used
RNAi-mediated knockdown of the protein. Three different
Stealth RNAi duplexes were designed with Block-iT RNAi
Designer (Invitrogen). The different RNAi constructs were
transiently transfected into control fibroblasts with Lipo-
fectamine RNAimax (Invitrogen) at a final concentration
of 12 nM. The transfections were repeated on days 3
and 6, and the cells were harvested and analyzed on
day 9. The Stealth KD2 duplex (50CAAACCAAAUCUGUU
GGGUUCUAAA-30) produced the most robust RMND1
knockdown (Figure 4D, top panel), so we continued the
BN-PAGE analysis with this construct. The OXPHOS-
assembly defects produced by RNAi-mediated knockdown
of RMND1 were very similar to those found in the RMND1
subject (Figure 4D), confirming that RMND1 is required for
normal assembly of the OXPHOS complexes.
We next asked whether RMND1 was part of a protein
complex. We isolated mitochondria from HEK cells stably
expressing RMND1-Myc, solubilized them, and analyzed
them by gel filtration as previously described.16 RMND1-
Myc and the endogenous RMND1 eluted in the frac-
tions between the peak fractions from COX (230 kDa,
Figure 5A) and LRPPRC10 (250 kDa, Figure 5A). To confirm
that RMND1 formed a high-molecular-weight complex,
we carried out a similar analysis by using BN-PAGE. The
complex containing RMND1 ran slightly slower than
that of COX on the first-dimension BN-PAGE, confirming
that it is approximately 240 kDa in size. Strikingly, this
complex almost completely failed to assemble in the
subject cells but was restored by retroviral expression of
wild-type RMND1-Myc (Figure 5B). These data indicate
that the mutation in the coiled-coil domain of RMND1
prevents the formation of a higher-order complex and
that the complex is essential for RMND1 function. To
establish whether the complex contained other proteins,
we immunoprecipitated RMND1-Myc with an Myc anti-
body and ran the immunoprecipitate on a BN-PAGE gel.
Mass-spectrometry analysis of the purified complex identi-
fied only RMND1 (data not shown). Although we cannot
rule out the presence of other proteins at the moment,
this analysis suggests that RMND1 very likely assembles
into a homopolymeric complex.
Although we do not know the exact molecular function
of RMND1, our data show that it is part of a large mito-
chondrial-membrane complex that is required for the
translation of the mitochondrially encoded polypeptidesThe Americand is thus essential for the biogenesis of the OXPHOS
complexes. The gene products of all the other members
of the RMD/SIF2 family localize to the cytoplasm or
nucleus and have a function in some aspect of meiosis or
sporulation in yeast species. Sif2p, for example, is part of
the Set3 histone deacetylase complex that represses a set
of meiotic genes.17 Although the function of Rmd1p, the
S. cerevisae homolog of RMND1, remains unknown, there
is no evidence that it has a role in mitochondrial transla-
tion or OXPHOS function. RMND1 has apparently evolved
a new function related to mitochondrial translation in
mammalian cells. The substantial decreases in the steady-
state levels in some of the mitochondrial ribosomal sub-
units and the relative decrease in the 16S rRNA in the
RMND1 subject cells both point to a role for RMND1 in
some aspect of the assembly or maintenance of the mito-
chondrial ribosome.
Ribosome assembly is a complex, highly coordinated
process in which protein binding and posttranscriptional
nucleotide modifications drive and stabilize rRNA struc-
tures until the native state is reached. How this is regu-
lated in mammalian mitochondria is largely unknown,
although a few ribosome-biogenesis factors have been
identified. ERAL118,19 and the PPR protein PTCD320 bind
and stabilize the 12S rRNA, and the mitochondrial tran-
scription factor TFB1M is responsible for dimethylating
two highly conserved adenines in a stem loop near the
30 end of the 12S rRNA.21,22 A GTPase, C4orf14 (NOA1),
associates with the mt-SSU, but its precise molecular role
has not been defined.23 Knockdown of any of these fac-
tors compromises mt-SSU assembly and mitochondrial
translation.an Journal of Human Genetics 91, 737–743, October 5, 2012 741
The only known protein that binds the 16S rRNA is
mTERF4, which forms a complex with the RNA dimethyl
transferase NSUN4 presumably to methylate a cytosine
residue (not yet identified) on the 16S rRNA.24 Interest-
ingly, a tissue-specific knockout of Mterf4 in the heart
results in a large increase in both mt-SSU and mt-LSU
without a corresponding increase in monosome forma-
tion, suggesting that it is not required for the assembly or
stability of the individual subunits per se. The GTPase
MTG1 is thought to play a role in mt-LSU assembly on the
basis of its ability to partially rescue a deletion of the yeast
ortholog, but its precise role has not been defined.25
Assembly of the mature ribosome requires proteolytic
processing of MRPL32, a task performed by the m-AAA
protease.26 C7orf30, a protein of the widely expressed
DUF143 family, was shown to associate with the mt-
LSU,27,28 specifically with MRPL14,29 but its role in the
assembly of mt-LSU and the downstream effects on trans-
lation remain controversial. Aside from the m-AAA pro-
tease in the list above, RMND1 stands out because of all
the proteins involved in ribosome biogenesis, it is the
only one that forms a membrane-anchored complex. We
speculate that this could act to stabilize or position the
mitochondrial ribosome perhaps by linking it through
to the outer membrane. Further detailed studies will be
necessary for testing this hypothesis.Acknowledgments
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